3 news items
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
VERO
25 Mar 24
to maximize shareholder value as part of the process announced on January 24, 2024. This includes engaging in dialogue with the Company's existing lenders
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB
ENVB
OCGN
RSCI
28 Feb 24
of medical aesthetic technology, revealed on February 23, 2024, that it had engaged in a registered direct offering, adhering to NASDAQ regulations
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
ARDX
DYAI
MEDS
28 Feb 24
, revealed on February 23, 2024, that it had engaged in a registered direct offering, adhering to NASDAQ regulations regarding market pricing. Under
- Prev
- 1
- Next